Cognitive Disorders and Drug Development Market 2018 | Aarkstore
Cognitive Disorders and Drug Development Market 2018 | Aarkstore The report provides an overview of the pipeline landscape for cognitive impairment disorders drug development . It provides comprehensive information on the therapeutics under development. key players involved in therapeutic development for cognitive impairment associated are: · Schizophrenia (CIAS) · Dementia · Mild cognitive impairment · Alzheimers disease · Features dormant · Discontinued products. Summary These disorders are associated with impairments in cognitive abilities such as learning, memory and perception. Due to the complex and highly sophisticated nature of the central nervous system (CNS)...